Holyrood, made browsable

Hansard

Every contribution to the Official Report — chamber and committee — searchable in one place. Pulled from data.parliament.scot, indexed for full-text search, linked through to every MSP.

129
Current MSPs
415
MSPs ever elected
13
Parties on record
2,355,091
Hansard contributions
1999–2026
Coverage span
Official Report

Search Hansard contributions

Clear
Showing 0 of 2,355,091 contributions in session S6, 17 Apr 2026 – 17 May 2026. Latest 30 days: 148. Coverage: 12 May 1999 — 14 May 2026.

No contributions match those filters.

← Back to list
Chamber

Meeting of the Parliament 20 February 2013

20 Feb 2013 · S4 · Meeting of the Parliament
Item of business
New Medicines
McDonald, Mark SNP North East Scotland Watch on SPTV
I know that Mr Carlaw was making a fleeting political point, but I will quote to him what Breakthrough Cancer Scotland said:

“Breakthrough would suggest that rather than introducing a Cancer Drugs Fund in Scotland at this stage, when it is likely to have limited impact before the implementation of VBP”—

value-based pricing—

“in 2014, a thorough review of the effectiveness of current drug access system in Scotland is undertaken.”

That review is under way.

Melanoma Action Support Scotland stated that it does not want

“a cancer drugs fund; treatment is required for other life limiting diseases too”,

and MacMillan Cancer Support stated:

“we do not support the introduction of a cancer drugs fund in Scotland”

In the same item of business

The Deputy Presiding Officer (John Scott) Con
The next item of business is a debate on motion S4M-05664, in the name of Jackson Carlaw, on health. 15:55
Jackson Carlaw (West Scotland) (Con) Con
The Conservatives have framed the motion with a view to making qualitative progress on the subject of cancer in this afternoon’s debate. In that spirit, we w...
Mark McDonald (North East Scotland) (SNP) SNP
Will the member take an intervention?
Jackson Carlaw Con
I will in due course.It is not a choice between detection and making drugs available—those are two halves of the approach that the Parliament should ensure i...
Mark McDonald SNP
I know that Mr Carlaw was making a fleeting political point, but I will quote to him what Breakthrough Cancer Scotland said:“Breakthrough would suggest that ...
Jackson Carlaw Con
The member has made his point. Many of the quotes used by Mark McDonald are from papers that were issued at the commencement of the cancer drugs fund in the ...
Joan McAlpine (South Scotland) (SNP) SNP
Will the member take an intervention?
Jackson Carlaw Con
No—I want to make the point.I am not someone who gets overly emotional in politics—I have been around long enough to know that the hard knocks come and they ...
The Cabinet Secretary for Health and Wellbeing (Alex Neil) SNP
This is a difficult and very sensitive subject. I think that we all recognise that making decisions about which medicines to provide for national health serv...
Jim Eadie (Edinburgh Southern) (SNP) SNP
Does the cabinet secretary recognise that public trust and confidence go to the heart of the debate, and that the public have a right to expect that if their...
Alex Neil SNP
I will deal with some of those points later in my speech.Thousands of medicines in various doses and formulations are available to clinicians in the UK. In S...
Jackie Baillie (Dumbarton) (Lab) Lab
I welcome the opportunity to debate access to new medicines in the NHS and the tone of the speeches made by Jackson Carlaw and the cabinet secretary. I also ...
The Deputy Presiding Officer (Elaine Smith) Lab
You are in your last minute.
Jackie Baillie Lab
Fourteen different ways of doing things is no longer acceptable.Let me turn to the orphan drugs fund. That is very welcome, but it must not just be a stickin...
The Deputy Presiding Officer Lab
The debate is extremely tight, and we have already lost a member from it. I ask members to take only their four minutes.16:18
Aileen McLeod (South Scotland) (SNP) SNP
I welcome the opportunity to debate a very serious and sensitive issue, particularly as a member of the Health and Sport Committee, as the issue forms part o...
Jackson Carlaw Con
I understand the point that the member is making, but she has just referred to the £21 million that has been made available for the rare conditions medicine ...
Aileen McLeod SNP
I speak as somebody who has worn both hats: one as a policy maker and one as a cancer victim and survivor. I am therefore acutely aware of how cancer suffere...
Duncan McNeil (Greenock and Inverclyde) (Lab) Lab
I am sure that we will hear a lot in the debate about the National Institute for Health and Clinical Excellence, the Scottish Medicines Consortium, individua...
Joan McAlpine SNP
I think that the member was referring to my article in the Daily Record and I thank him for taking an intervention from me, which Mr Carlaw did not have the ...
The Deputy Presiding Officer Lab
Please be brief.
Joan McAlpine SNP
Does the member agree that there is an issue to do with pharmaceutical companies holding the health service to ransom—
Duncan McNeil Lab
The member will speak in the debate. I hope that I will be given additional time.
The Deputy Presiding Officer Lab
I am afraid that this is a very short debate.
Duncan McNeil Lab
I accept that the premise of Ms McAlpine’s article was that politicians should not be involved in the process at all. However, we set the parameters and we p...
The Deputy Presiding Officer Lab
You must conclude, Mr McNeil.
Duncan McNeil Lab
That is why the cabinet secretary instigated a review of the process. It matters that we lost precious time. That time was not as precious for us as it was f...
The Deputy Presiding Officer Lab
I advise members that we might have to lose another speaker from the debate. Members must take interventions in their own time.16:26
Bob Doris (Glasgow) (SNP) SNP
I welcome the debate, although I cannot accept the Conservative motion. I will explain to Jackson Carlaw why that is the case. Mr Carlaw will not share this ...
Dr Richard Simpson (Mid Scotland and Fife) (Lab) Lab
That is the clinician’s decision.